To access this element change to forms mode OFF
Grant Award View - GA69441
Developing a safe and efficacious vaccine for the Buruli ulcer
GA ID:
GA69441
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
20-Jan-2020
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$132,741.92
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Developing a safe and efficacious vaccine for the Buruli ulcer
Purpose:
The aim of this project is to develop a safe and effective vaccine for Buruli ulcer, caused by the bacteria Mycobacterium ulcerans. M. ulcerans produces a toxin known as “mycolactone”, which causes breakdown of the skin and suppresses the immune system. This study will perform a number of experiments in mice with a new vaccine that targets the mycolactone toxin, while also investigating the immune system’s response to infection, in order to predict the best vaccines that will prevent infection.
GO ID:
GO Title:
NHMRC Postgraduate Scholarships for funding commencing in 2020
Internal Reference ID:
GNT1191368
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA